BioCentury
ARTICLE | Clinical News

BNC105: Interim Phase II data

August 8, 2011 7:00 AM UTC

Interim data from a single-arm, Australian Phase II trial in 24 evaluable patients who progressed after first-line chemotherapy with Alimta pemetrexed and cisplatin showed that second-line treatment ...